Rystiggo® (Rozanolixizumab-noli) IV Infusion Therapy in Miami

Targeted Therapy for Generalized Myasthenia Gravis (gMG)

Clearwell Infusion Centers offers Rystiggo infusion therapy for patients living with generalized myasthenia gravis. Located in Miami, our center provides private infusion suites, compassionate care, and flexible scheduling—making it easier for patients to access the treatment they need.

What Is Rystiggo?

Rystiggo® (rozanolixizumab-noli) is an FDA-approved monoclonal antibody that treats generalized myasthenia gravis (gMG) in adult patients who are anti-AChR or anti-MuSK antibody positive. It works by targeting the neonatal Fc receptor (FcRn), reducing levels of disease-causing IgG antibodies that attack communication between nerves and muscles.

Rystiggo is administered as a once-weekly subcutaneous infusion, typically over a six-week course.

Learn more at the official Rystiggo website.

Condition Treated with Rystiggo

Rystiggo is indicated for:

• Generalized Myasthenia Gravis (gMG) in adults who are:
  • Anti-AChR antibody positive, or
  • Anti-MuSK antibody positive

It offers a targeted option for patients who have not achieved adequate symptom control with standard therapies such as corticosteroids or immunosuppressants.

Rystiggo Side Effects

Rystiggo is generally well tolerated, though potential side effects include:

• Headache
• Diarrhea
• Fever
• Chills or flu-like symptoms
• Injection site reactions
• Increased risk of infection

At Clearwell, all treatments are administered by trained infusion nurses in accordance with ACHC-accredited clinical protocols and under close supervision.

For full safety information, view the Rystiggo prescribing information.

Why Choose Clearwell for Your Rystiggo Infusion?

Clearwell Infusion Centers makes specialty care more accessible, comfortable, and reliable. When you choose Clearwell for Rystiggo treatment, you benefit from:

• Private treatment suites with spa-like amenities
• Low patient-to-nurse ratio for attentive care
• Flexible appointment times, including weekends and evenings
• Comprehensive insurance coordination, including prior authorizations and benefits checks
• ACHC-accredited facility and safety standards
• Close coordination with your prescribing provider and care team

Rystiggo is typically administered weekly for six weeks, with dosing based on patient weight.

Getting Started with Rystiggo

If your neurologist has prescribed Rystiggo, Clearwell can help you get started quickly. We’ll work with your care team, handle insurance approvals, and schedule your weekly treatments in a way that fits your life.

Have questions? Call us at 305‑306‑7147 or email contact@clearwellinfusion.com.

Referring Providers: Partner with Clearwell Infusion Centers

We work closely with neurologists and neuromuscular specialists across South Florida to safely administer Rystiggo infusions in an outpatient setting.

Why refer to Clearwell?

• Quick turnaround on benefits verification and authorizations
• Simple referral process
• Timely clinical summaries and patient updates
• Experienced nursing team familiar with neuromuscular therapies
• ACHC-accredited facility focused on patient safety

To refer a patient for Rystiggo infusion therapy in Miami, contact our provider team at referrals@clearwellinfusion.comor call 305‑306‑7147.

Looking to start your Rystiggo treatment at Clearwell Infusion Centers?

Fill out the form below and a member of our team will contact you